138 related articles for article (PubMed ID: 32066096)
1. Changes in long term peripheral nerve biophysical properties in childhood cancer survivors following neurotoxic chemotherapy.
Kandula T; Farrar MA; Cohn RJ; Carey KA; Johnston K; Kiernan MC; Krishnan AV; Park SB
Clin Neurophysiol; 2020 Apr; 131(4):783-790. PubMed ID: 32066096
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.
Ness KK; Jones KE; Smith WA; Spunt SL; Wilson CL; Armstrong GT; Srivastava DK; Robison LL; Hudson MM; Gurney JG
Arch Phys Med Rehabil; 2013 Aug; 94(8):1451-7. PubMed ID: 23537607
[TBL] [Abstract][Full Text] [Related]
4. Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor.
Solheim O; Skalleberg J; Warncke T; Ørstavik K; Tropé C; Fosså SD
Acta Obstet Gynecol Scand; 2019 Feb; 98(2):240-249. PubMed ID: 30289161
[TBL] [Abstract][Full Text] [Related]
5. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
6. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function.
Krarup-Hansen A; Fugleholm K; Helweg-Larsen S; Hauge EN; Schmalbruch H; Trojaborg W; Krarup C
Brain; 1993 Oct; 116 ( Pt 5)():1017-41. PubMed ID: 8221046
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
8. [Superiority of intrafascicular neurography over conventional nerve conduction studies in evaluating axonal degeneration].
Hasegawa O; Matsumoto S; Iino M; Kurita R; Yoshii T
No To Shinkei; 1999 Apr; 51(4):313-6. PubMed ID: 10363265
[TBL] [Abstract][Full Text] [Related]
9. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
[TBL] [Abstract][Full Text] [Related]
10. Acute changes in nerve excitability following oxaliplatin treatment in mice.
Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G
J Neurophysiol; 2020 Jul; 124(1):232-244. PubMed ID: 32519566
[TBL] [Abstract][Full Text] [Related]
11. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.
Ramchandren S; Leonard M; Mody RJ; Donohue JE; Moyer J; Hutchinson R; Gurney JG
J Peripher Nerv Syst; 2009 Sep; 14(3):184-9. PubMed ID: 19909482
[TBL] [Abstract][Full Text] [Related]
12. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
[TBL] [Abstract][Full Text] [Related]
13. Vincristine-induced neuropathy: Atypical electrophysiological patterns in children.
Courtemanche H; Magot A; Ollivier Y; Rialland F; Leclair-Visonneau L; Fayet G; Camdessanché JP; Péréon Y
Muscle Nerve; 2015 Dec; 52(6):981-5. PubMed ID: 25758843
[TBL] [Abstract][Full Text] [Related]
14. Vincristine induced neurotoxicity in cancer patients.
Gomber S; Dewan P; Chhonker D
Indian J Pediatr; 2010 Jan; 77(1):97-100. PubMed ID: 19936661
[TBL] [Abstract][Full Text] [Related]
15. Newly identified chemotherapy-induced peripheral neuropathy in a childhood cancer survivorship clinic.
Rodwin RL; Ross WL; Rotatori J; Allen K; Auerbach C; Balsamo LM; Kadan-Lottick NS
Pediatr Blood Cancer; 2022 Mar; 69(3):e29550. PubMed ID: 34971076
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in drug-induced neuropathies.
Peltier AC; Russell JW
Curr Opin Neurol; 2002 Oct; 15(5):633-8. PubMed ID: 12352008
[TBL] [Abstract][Full Text] [Related]
17. Sensory nerve excitability and neuropathy in end stage kidney disease.
Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Kiernan MC
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):548-51. PubMed ID: 16543542
[TBL] [Abstract][Full Text] [Related]
18. The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors.
Mohrmann C
J Pediatr Oncol Nurs; 2019; 36(6):413-423. PubMed ID: 31057036
[TBL] [Abstract][Full Text] [Related]
19. [Neuropathy induced by antineoplastic drugs].
Kusunoki J; Saito T
Brain Nerve; 2008 Feb; 60(2):131-6. PubMed ID: 18306660
[TBL] [Abstract][Full Text] [Related]
20. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
